Bacteria are the leading cause of infections after solid organ transplantation. In recent years,
a progressive growth in the incidence of multidrug‐resistant (MDR) and extensively‐drug …

The number of lung transplantations is progressively increasing worldwide, providing new
challenges to interprofessional teams and the intensive care units. The outcome of lung …

Few studies have examined the lung virome in health and disease. Outcomes of lung
transplantation are known to be influenced by several recognized respiratory viruses, but …

Hyperammonemia syndrome is a fatal complication affecting immunosuppressed patients.
Frequently refractory to treatment, it is characterized by progressive elevations in serum …

Factors contributing to donor-specific HLA antibody (DSA) development after lung
transplantation have not been systematically evaluated. We hypothesized that the isolation …

As lung transplantation has become the most effective definitive treatment option for end-
stage chronic respiratory diseases, yearly rates of this surgery have been steadily …

Background Bacterial infections remain a challenge to solid organ transplantation. Due to
the alarming spread of carbapenem-resistant gram negative bacteria, these organisms have …

Lung transplantation has lower survival rates compared to other than other solid organ
transplants (SOT) due to higher rates of infection and rejection-related complications, and …

Background Cytomegalovirus (CMV) is the major and most common opportunistic infection
complicating lung transplant (LTX). The aim of this study was to analyse the epidemiological …

Solid organ transplantation disrupts virus-host relationships, potentially resulting in viral
transfer from donor to recipient, reactivation of latent viruses, and new viral infections. Viral …